Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vital Capacity"" wg kryterium: Temat


Tytuł :
A comparative analysis of lung function and spirometry parameters in genotype-controlled natives living at low and high altitude.
Autorzy :
Ortiz-Prado E; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador. .; Department of Cell Biology, Physiology and Immunology, Universidad de Barcelona, Barcelona, Spain. .
Encalada S; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador.
Mosquera J; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador.
Simbaña-Rivera K; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador.
Gomez-Barreno L; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador.
Duta D; Limoncocha Community Health Unit, Limoncocha, Ecuador.
Ochoa I; Oyacachi Community Health Unit, Oyacachi, Ecuador.
Izquierdo-Condoy JS; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador.
Vasconez E; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador.
Burgos G; Faculty of Medicine, Universidad de las Américas, Quito, Ecuador.
Calvopiña M; One Health Research Group, Faculty of Medicine, Universidad de las Américas, Calle de los Colimes y Avenida De los Granados, 170137, Quito, Ecuador.
Viscor G; Department of Cell Biology, Physiology and Immunology, Universidad de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
BMC pulmonary medicine [BMC Pulm Med] 2022 Mar 21; Vol. 22 (1), pp. 100. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Altitude*
Forced Expiratory Volume*
Vital Capacity*
Lung/*physiology
Adult ; Aged ; Cross-Sectional Studies ; Ecuador ; Female ; Humans ; Indigenous Peoples ; Male ; Middle Aged ; Partial Pressure ; Spirometry
Czasopismo naukowe
Tytuł :
Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study.
Autorzy :
Wu W; Department of Rheumatology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu W; Department of Rheumatology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Sun W; Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Zhang D; Department of Rheumatology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhao J; Department of Rheumatology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Luo Q; State Key Laboratory of Respiratory Disease, National Clinical Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Wang X; Department of Rheumatology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu F; Department of Pulmonology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zheng Y; Department of Pulmonology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xue Y; Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
Wan W; Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
Wu H; Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Han Q; State Key Laboratory of Respiratory Disease, National Clinical Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Ye S; Department of Rheumatology, Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 Dec 24; Vol. 61 (1), pp. 230-239.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Vital Capacity*
Dermatomyositis/*mortality
Dermatomyositis/*physiopathology
Lung Diseases, Interstitial/*mortality
Lung Diseases, Interstitial/*physiopathology
Adult ; Cohort Studies ; Dermatomyositis/genetics ; Disease Progression ; Female ; Humans ; Interferon-Induced Helicase, IFIH1/genetics ; Lung Diseases, Interstitial/genetics ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
Autorzy :
Wan ES; Channing Division of Network Medicine, Brigham & Women's Hospital, Boston, Massachusetts.; VA Boston Healthcare System, Boston, Massachusetts.
Balte P; Columbia University, New York, New York.
Schwartz JE; Columbia University, New York, New York.; Renaissance School of Medicine at Stony Brook University, Stony Brook, New York.
Bhatt SP; University of Alabama at Birmingham.
Cassano PA; Cornell University, Ithaca, New York.
Couper D; University of North Carolina at Chapel Hill.
Daviglus ML; Institute for Minority Health Research, University of Illinois College of Medicine, Chicago.
Dransfield MT; University of Alabama at Birmingham.
Gharib SA; Computational Medicine Core, Center for Lung Biology, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle.
Jacobs DR Jr; University of Minnesota, Minneapolis.
Kalhan R; Northwestern University, Chicago, Illinois.
London SJ; National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina.
Navas-Acien A; Columbia University, New York, New York.
O'Connor GT; Boston University, Boston, Massachusetts.
Sanders JL; Division of Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, Massachusetts.
Smith BM; McGill University, Montreal, Quebec, Canada.
White W; Tougaloo College, Tougaloo, Mississippi.
Yende S; University of Pittsburgh, Pittsburgh, Pennsylvania.
Oelsner EC; Columbia University, New York, New York.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 Dec 14; Vol. 326 (22), pp. 2287-2298.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Forced Expiratory Volume*
Spirometry*
Vital Capacity*
Lung Diseases/*physiopathology
Adult ; Aged ; Aged, 80 and over ; Cardiovascular Diseases/etiology ; Female ; Humans ; Lung/physiopathology ; Lung Diseases/complications ; Lung Diseases/epidemiology ; Lung Diseases/mortality ; Male ; Middle Aged ; Prevalence ; Retrospective Studies ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.
Autorzy :
Nathan SD; Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA. Electronic address: .
Waxman A; Pulmonary and Critical Care Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Rajagopal S; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Case A; Piedmont Healthcare, Austell, GA, USA.
Johri S; Pulmonary Associates of Richmond, Richmond, VA, USA.
DuBrock H; Department of Internal Medicine, Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN, USA.
De La Zerda DJ; Division of Pulmonary & Critical Care Medicine, University of Miami Health System, Miami, FL, USA.
Sahay S; Division of Pulmonary, Critical Care and Sleep Medicine, Houston Methodist Hospital, Houston, TX, USA.
King C; Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA.
Melendres-Groves L; Pulmonary & Critical Care Division, University of New Mexico, 1 University of New Mexico, DoIM MSC10-5550, Albuquerque, NM, USA.
Smith P; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Shen E; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Edwards LD; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Nelsen A; United Therapeutics Corporation, Research Triangle Park, NC, USA.
Tapson VF; Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Nov; Vol. 9 (11), pp. 1266-1274. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hypertension, Pulmonary*/etiology
Lung Diseases, Interstitial*/complications
Lung Diseases, Interstitial*/drug therapy
Vital Capacity*/drug effects
Epoprostenol/*analogs & derivatives
Adolescent ; Adult ; Double-Blind Method ; Epoprostenol/administration & dosage ; Epoprostenol/adverse effects ; Epoprostenol/pharmacology ; Humans ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review.
Autorzy :
Zang C; Department of Respiratory and Critical Care Medicine, Qingdao Hospital of Traditional Chinese Medicine(Qingdao Hiser Hospital), No.4 Renmin Road, Shibei District, Qingdao, 266000, Shandong Province, China.
Zheng Y; Department of General Practice, Qingdao Hospital of Traditional Chinese Medicine(Qingdao Hiser hospital), Qingdao, China.
Wang Y; Department of Respiratory and Critical Care Medicine, Qingdao Hospital of Traditional Chinese Medicine(Qingdao Hiser Hospital), No.4 Renmin Road, Shibei District, Qingdao, 266000, Shandong Province, China.
Li L; Department of Respiratory and Critical Care Medicine, Qingdao Hospital of Traditional Chinese Medicine(Qingdao Hiser Hospital), No.4 Renmin Road, Shibei District, Qingdao, 266000, Shandong Province, China. .
Pokaż więcej
Źródło :
European journal of medical research [Eur J Med Res] 2021 Oct 30; Vol. 26 (1), pp. 129. Date of Electronic Publication: 2021 Oct 30.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Idiopathic Pulmonary Fibrosis/*drug therapy
Lung/*drug effects
Pyridones/*therapeutic use
Vital Capacity/*drug effects
Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Diarrhea/chemically induced ; Exanthema/chemically induced ; Humans ; Idiopathic Pulmonary Fibrosis/physiopathology ; Lung/pathology ; Lung/physiopathology ; Nausea/chemically induced ; Progression-Free Survival ; Pyridones/adverse effects ; Treatment Outcome ; Vital Capacity/physiology
Czasopismo naukowe
Tytuł :
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
Autorzy :
Frija-Masson J; Université de Paris, Neurodiderot, Inserm, F-75018, Paris, France; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France. Electronic address: .
Debray MP; Université de Paris, Inserm U 1152, F-75018, Paris, France; Service de Radiologie, Hôpital Bichat Claude Bernard, F-75018, Paris, France.
Boussouar S; Sorbonne Université, Laboratoire D'imagerie Biomédicale, INSERM, ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Cardiothoracic Imaging Unit, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, F-75013, Paris, France.
Khalil A; Université de Paris, Inserm U 1152, F-75018, Paris, France; Service de Radiologie, Hôpital Bichat Claude Bernard, F-75018, Paris, France.
Bancal C; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France.
Motiejunaite J; Université de Paris, Neurodiderot, Inserm, F-75018, Paris, France; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France.
Galarza-Jimenez MA; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service des Explorations Fonctionnelles de La Respiration, de L'exercice et de La Dyspnée (Département R3S), F-75013, Paris, France.
Benzaquen H; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France.
Penaud D; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France.
Laveneziana P; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service des Explorations Fonctionnelles de La Respiration, de L'exercice et de La Dyspnée (Département R3S), F-75013, Paris, France.
Malrin R; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service de Pneumologie, SSR (Département R3S), F-75013, Paris, France.
Redheuil A; Sorbonne Université, Laboratoire D'imagerie Biomédicale, INSERM, ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Cardiothoracic Imaging Unit, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, F-75013, Paris, France.
Donciu V; Université de La Sorbonne, Paris, France.
Lucidarme O; Université de La Sorbonne, Paris, France; Assistance Publique, Hôpitaux de Paris, Service de Radiologie, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, F-75013, Paris, France.
Taillé C; Université de Paris, Inserm U 1152, F-75018, Paris, France; Service de Pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat Claude Bernard, F-75018, Paris, France.
Guerder A; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service de Pneumologie, SSR (Département R3S), F-75013, Paris, France.
Arnoult F; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France.
Vidal-Petiot E; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France; Université de Paris, Inserm U 1149, Center for Research in Inflammation, F-75018, Paris, France.
Flamant M; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France; Université de Paris, Inserm U 1149, Center for Research in Inflammation, F-75018, Paris, France.
Similowski T; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation (Département R3S), F-75013, Paris, France.
Morelot-Panzini C; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation (Département R3S), F-75013, Paris, France.
Faure M; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation (Département R3S), F-75013, Paris, France.
Lescure FX; Université de Paris, Inserm U 1137, F-75018, Paris, France; Service de Maladies Infectieuses et Tropicales, Assistance Publique Hôpitaux de Paris, Hôpital Bichat Claude Bernard, F-75018, Paris, France.
Straus C; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service des Explorations Fonctionnelles de La Respiration, de L'exercice et de La Dyspnée (Département R3S), F-75013, Paris, France.
d'Ortho MP; Université de Paris, Neurodiderot, Inserm, F-75018, Paris, France; Physiologie-Explorations Fonctionnelles, FHU APOLLO, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, F-75018, Paris, France.
Gonzalez-Bermejo J; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service de Pneumologie, SSR (Département R3S), F-75013, Paris, France.
Pokaż więcej
Źródło :
Respiratory medicine [Respir Med] 2021 Aug; Vol. 184, pp. 106435. Date of Electronic Publication: 2021 May 15.
Typ publikacji :
Journal Article
MeSH Terms :
Forced Expiratory Volume*
Vital Capacity*
COVID-19/*diagnostic imaging
COVID-19/*physiopathology
Lung/*diagnostic imaging
Female ; Humans ; Lung/physiopathology ; Male ; Middle Aged ; Radiography, Thoracic ; Respiratory Function Tests ; Retrospective Studies ; Severity of Illness Index ; Time Factors ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Physical performance in relation to preserved ratio impaired spirometry: a cross-sectional study of community-dwelling older Japanese adults.
Autorzy :
Anami K; Department of Rehabilitation, Faculty of Health Sciences, Naragakuen University, 3-15-1, Nakatomigaoka, Nara-shi, Nara, 631-8524, Japan. .
Murata S; Department of Physical Therapy, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, 607-8175, Japan.
Nakano H; Department of Physical Therapy, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, 607-8175, Japan.
Nonaka K; Department of Rehabilitation, Faculty of Health Sciences, Naragakuen University, 3-15-1, Nakatomigaoka, Nara-shi, Nara, 631-8524, Japan.
Iwase H; Department of Physical Therapy, Faculty of Rehabilitation, Kobe International University, Kobe, 658-0032, Japan.
Shiraiwa K; Department of Physical Therapy, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, 607-8175, Japan.
Abiko T; Department of Physical Therapy, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, 607-8175, Japan.
Goda A; Department of Physical Therapy, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, 607-8175, Japan.
Horie J; Department of Physical Therapy, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, 607-8175, Japan.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Aug 31; Vol. 11 (1), pp. 17411. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Physical Functional Performance*
Vital Capacity*
Independent Living/*statistics & numerical data
Lung/*physiopathology
Spirometry/*methods
Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Female ; Forced Expiratory Volume ; Humans ; Japan ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Natural history of lung function over one year in patients with Parkinson's disease.
Autorzy :
Kaminsky DA; Larner College of Medicine, University of Vermont, Burlington, VT, USA. Electronic address: .
Grosset DG; Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK.
Kegler-Ebo DM; Acorda Therapeutics, Inc., Ardsley, NY, USA.
Cangiamilla S; Acorda Therapeutics, Inc., Ardsley, NY, USA.
Klingler M; Acorda Therapeutics, Inc., Ardsley, NY, USA.
Zhao P; Acorda Therapeutics, Inc., Ardsley, NY, USA.
Oh C; Acorda Therapeutics, Inc., Ardsley, NY, USA.
Pokaż więcej
Źródło :
Respiratory medicine [Respir Med] 2021 Jun; Vol. 182, pp. 106396. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Forced Expiratory Volume*
Vital Capacity*
Parkinson Disease/*physiopathology
Administration, Inhalation ; Aged ; Cohort Studies ; Female ; Humans ; Levodopa/administration & dosage ; Male ; Middle Aged ; Parkinson Disease/drug therapy ; Randomized Controlled Trials as Topic ; Respiratory Function Tests ; Time Factors
Czasopismo naukowe
Tytuł :
Vitamin D deficiency and lung function decline in healthy individuals: A large longitudinal observation study.
Autorzy :
Ahn KM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kim SS; Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Republic of Korea.
Lee SY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Lee SH; Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Republic of Korea.
Park HW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Respiratory medicine [Respir Med] 2021 Jun; Vol. 182, pp. 106395. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Forced Expiratory Volume*
Healthy Volunteers*
Vital Capacity*
Vitamin D Deficiency/*physiopathology
Female ; Humans ; Longitudinal Studies ; Male ; Risk ; Smoking/adverse effects ; Smoking/physiopathology
Czasopismo naukowe
Tytuł :
Lung Function Decline in Relation to COVID-19 in the General Population: A Matched Cohort Study With Prepandemic Assessment of Lung Function.
Autorzy :
Iversen KK; Department of Infectious Diseases 144, Copenhagen University Hospital-Amager Hvidovre, Hvidovre, Denmark.
Afzal S; Department of Clinical Biochemistry, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; The Copenhagen General Population Study, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Ahlström MG; Department of Clinical Microbiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Nordestgaard BG; Department of Clinical Biochemistry, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; The Copenhagen General Population Study, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Schneider UV; Department of Clinical Microbiology, Copenhagen University Hospital-Amager Hvidovre, Hvidovre, Denmark.
Nielsen L; Department of Clinical Microbiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
Kofoed K; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Benfield T; Department of Infectious Diseases 144, Copenhagen University Hospital-Amager Hvidovre, Hvidovre, Denmark.
Ronit A; Department of Infectious Diseases 144, Copenhagen University Hospital-Amager Hvidovre, Hvidovre, Denmark.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2022 Apr 19; Vol. 225 (8), pp. 1308-1316.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Adult ; Cohort Studies ; Humans ; Lung ; Prospective Studies ; SARS-CoV-2 ; Vital Capacity
Czasopismo naukowe
Tytuł :
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases.
Autorzy :
Brown KK; Department of Medicine, National Jewish Health, Denver, Colorado, USA.
Inoue Y; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Japan.
Flaherty KR; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Martinez FJ; Weill Cornell Medicine, New York, New York, USA.
Cottin V; National Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.
Bonella F; Center for Interstitial and Rare Lung Diseases, Department of Pneumology, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany.
Cerri S; Center for Rare Lung Disease, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.
Danoff SK; Johns Hopkins Medicine, Baltimore, Maryland, USA.
Jouneau S; Department of Respiratory Medicine, Competences Centre for Rare Pulmonary Diseases, CHU Rennes, IRSET UMR 1085, Univ Rennes, Rennes, France.
Goeldner RG; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Schmidt M; Boehringer Ingelheim Pharma GmbH, Ingelheim am Rhein, Germany.
Stowasser S; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Schlenker-Herceg R; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
Wells AU; National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, and National Heart and Lung Institute, Imperial College, London, UK.
Pokaż więcej
Źródło :
Respirology (Carlton, Vic.) [Respirology] 2022 Apr; Vol. 27 (4), pp. 294-300. Date of Electronic Publication: 2022 Feb 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Idiopathic Pulmonary Fibrosis*
Lung Diseases, Interstitial*
Disease Progression ; Humans ; Indoles ; Lung ; Vital Capacity
Czasopismo naukowe
Tytuł :
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates.
Autorzy :
Catalano A; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy. .
Vita GL; Nemo Sud Clinical Centre for Neuromuscular Disorders, Aurora Onlus Foundation, University Hospital 'G. Martino', Messina, Italy.
Bellone F; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy.
Sframeli M; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy.; Nemo Sud Clinical Centre for Neuromuscular Disorders, Aurora Onlus Foundation, University Hospital 'G. Martino', Messina, Italy.
Distefano MG; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy.
La Rosa M; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy.
Gaudio A; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Vita G; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy.; Nemo Sud Clinical Centre for Neuromuscular Disorders, Aurora Onlus Foundation, University Hospital 'G. Martino', Messina, Italy.
Morabito N; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy.
Messina S; Department of Clinical and Experimental Medicine, A.O.U. Policlinico 'G. Martino', University of Messina, Via C. Valeria, 98125, Messina, Italy.; Nemo Sud Clinical Centre for Neuromuscular Disorders, Aurora Onlus Foundation, University Hospital 'G. Martino', Messina, Italy.
Pokaż więcej
Źródło :
Journal of endocrinological investigation [J Endocrinol Invest] 2022 Mar; Vol. 45 (3), pp. 517-525. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Fractures, Bone*/epidemiology
Fractures, Bone*/etiology
Fractures, Bone*/prevention & control
Muscular Dystrophy, Duchenne*/diagnosis
Muscular Dystrophy, Duchenne*/drug therapy
Muscular Dystrophy, Duchenne*/metabolism
Muscular Dystrophy, Duchenne*/physiopathology
Ventricular Dysfunction, Left*/diagnosis
Ventricular Dysfunction, Left*/etiology
Adaptor Proteins, Signal Transducing/*metabolism
Collagen Type I/*metabolism
Glucocorticoids/*therapeutic use
Peptides/*metabolism
Adolescent ; Biomarkers/metabolism ; Bone Density ; Bone Remodeling ; Humans ; Italy/epidemiology ; Lumbar Vertebrae/diagnostic imaging ; Lumbar Vertebrae/pathology ; Mobility Limitation ; Stroke Volume ; Vital Capacity
Czasopismo naukowe
Tytuł :
骨水泥间隔灌注联合体位复位治疗高龄骨质疏松性椎体压缩骨折.
Autorzy :
车艳军
胡 丹
司卫兵
顾雪平
郝跃峰
Pokaż więcej
Alternatywny tytuł :
Bone cement interval perfusion in hyperextension position for treatment of senile osteoporotic vertebral compression fractures.
Źródło :
Chinese Journal of Tissue Engineering Research / Zhongguo zu zhi gong cheng yan jiu. 4/8/2022, Vol. 22 Issue 10, p1555-1561. 7p.
Czasopismo naukowe
Tytuł :
Serial 6-month change in forced vital capacity predicts subsequent decline and mortality in Japanese patients with newly diagnosed idiopathic pulmonary fibrosis.
Autorzy :
Toi Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Takei R; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Fukuoka J; Department of Laboratory of Pathology, Nagasaki University Hospital, Nagasaki, Japan.
Johkoh T; Department of Radiology, Kansai Rosai Hospital, Amagasaki, Japan.
Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan. Electronic address: .
Pokaż więcej
Źródło :
Respiratory investigation [Respir Investig] 2021 May; Vol. 59 (3), pp. 335-341. Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article
MeSH Terms :
Vital Capacity*
Idiopathic Pulmonary Fibrosis/*mortality
Idiopathic Pulmonary Fibrosis/*physiopathology
Lung/*physiopathology
Aged ; Aged, 80 and over ; Asians ; Female ; Humans ; Idiopathic Pulmonary Fibrosis/diagnosis ; Japan/epidemiology ; Male ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Time Factors
Czasopismo naukowe
Tytuł :
Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity.
Autorzy :
Sekine A; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan. Electronic address: .
Wasamoto S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Hagiwara E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Yamakawa H; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan; Department of Respiratory Medicine, Saitama Red Cross Hospital, Japan.
Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Okabayashi H; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Oda T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Okuda R; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Kitamura H; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Baba T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Komatsu S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan.
Pokaż więcej
Źródło :
Respiratory investigation [Respir Investig] 2021 Mar; Vol. 59 (2), pp. 247-251. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article
MeSH Terms :
Functional Residual Capacity*
Pulmonary Diffusing Capacity*
Vital Capacity*
Lung Diseases, Interstitial/*complications
Lung Diseases, Interstitial/*physiopathology
Obesity/*complications
Obesity/*physiopathology
Weight Loss/*physiology
Adult ; Aged ; Body Mass Index ; Carbon Monoxide/metabolism ; Female ; Follow-Up Studies ; Humans ; Lung Diseases, Interstitial/diagnostic imaging ; Male ; Middle Aged ; Positron-Emission Tomography ; Respiratory Function Tests ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Differential Effects of Cannabis and Tobacco on Lung Function in Mid-Adult Life.
Autorzy :
Hancox RJ; Department of Preventive and Social Medicine, Dunedin School of Medicine.
Gray AR; Biostatistics Centre, Division of Health Sciences, and.
Zhang X; Department of Preventive and Social Medicine, Dunedin School of Medicine.
Poulton R; Dunedin Multidisciplinary Health and Development Research Unit, Department of Psychology, University of Otago, Dunedin, New Zealand.
Moffitt TE; Department of Psychology and Neuroscience.; Department of Psychiatry and Behavioral Sciences, and.; Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina; and.
Caspi A; Department of Psychology and Neuroscience.; Department of Psychiatry and Behavioral Sciences, and.; Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina; and.
Sears MR; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2022 May 15; Vol. 205 (10), pp. 1179-1185.
Typ publikacji :
Journal Article
MeSH Terms :
Cannabis*
Lung*/drug effects
Lung*/physiology
Marijuana Smoking*
Smoking*
Tobacco Use*
Adult ; Age Factors ; Cohort Studies ; Forced Expiratory Volume ; Humans ; Middle Aged ; Spirometry ; Transfer Factor ; Vital Capacity ; Young Adult
Czasopismo naukowe
Tytuł :
Behavioural and psychological patterns of patients with idiopathic pulmonary fibrosis: a prospective study.
Autorzy :
Delameillieure A; Department of Chronic Diseases and Metabolism, Laboratory of Respiratory Diseases and Thoracic Surgery, KU Leuven, Kapucijnenvoer 35 blok D-box 7001, 3000, Leuven, Belgium. .; Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium. .
Dobbels F; Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium.
Fieuws S; L-BioStat, Louvain Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium.
Leceuvre K; Department of Respiratory Diseases, Unit for Interstitial Lung Diseases, University Hospitals Leuven, Leuven, Belgium.
Vanderauwera S; Department of Respiratory Diseases, Unit for Interstitial Lung Diseases, University Hospitals Leuven, Leuven, Belgium.
Wuyts WA; Department of Chronic Diseases and Metabolism, Laboratory of Respiratory Diseases and Thoracic Surgery, KU Leuven, Kapucijnenvoer 35 blok D-box 7001, 3000, Leuven, Belgium.; Department of Respiratory Diseases, Unit for Interstitial Lung Diseases, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Respiratory research [Respir Res] 2022 May 14; Vol. 23 (1), pp. 124. Date of Electronic Publication: 2022 May 14.
Typ publikacji :
Journal Article
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/epidemiology
Aged ; Aged, 80 and over ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Female ; Humans ; Lung ; Male ; Middle Aged ; Prospective Studies ; Pyridones/therapeutic use ; Quality of Life ; Treatment Outcome ; Vital Capacity
Czasopismo naukowe
Tytuł :
Association Between Serum Uric Acid and Lung Function in People with and without Chronic Obstructive Pulmonary Disease.
Autorzy :
Yang H; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Wang Z; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Xiao S; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Dai C; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Wen X; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Wu F; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.; Guangzhou Laboratory, Bio-Island, Guangzhou, People's Republic of China.
Peng J; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Tian H; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Zhou Y; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.; Guangzhou Laboratory, Bio-Island, Guangzhou, People's Republic of China.
Ran P; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.; Guangzhou Laboratory, Bio-Island, Guangzhou, People's Republic of China.
Pokaż więcej
Źródło :
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2022 May 05; Vol. 17, pp. 1069-1080. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Pulmonary Disease, Chronic Obstructive*/diagnosis
Cross-Sectional Studies ; Forced Expiratory Volume ; Humans ; Lung ; Uric Acid ; Vital Capacity
Czasopismo naukowe
Tytuł :
Annual FEV 1 Loss in Patients with Noncystic Fibrosis Bronchiectasis and Affecting Factors.
Autorzy :
Borekci S; From the Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa, Istanbul, Turkey.
Gundogdu S; From the Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa, Istanbul, Turkey.
Harbiyeli DO; From the Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa, Istanbul, Turkey.
Musellim B; From the Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa, Istanbul, Turkey.
Pokaż więcej
Źródło :
Southern medical journal [South Med J] 2022 May; Vol. 115 (5), pp. 328-332.
Typ publikacji :
Journal Article
MeSH Terms :
Bronchiectasis*/complications
Adult ; Aged ; Female ; Fibrosis ; Humans ; Male ; Middle Aged ; Respiratory Function Tests ; Retrospective Studies ; Vital Capacity
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies